Microvascular and systemic responses to novel PEGylated carboxyhaemoglobin-based oxygen carrier in a rat model of vaso-occlusive crisis
Source abstract
Abstract
Hypoxia drives sickle cell disease (SCD) by inducing sickle cell haemoglobin to polymerize and deform red blood cells (RBC) into the sickle shape. A novel carboxyhaemoglobin-based oxygen carrier (PEG-COHb; PP-007) promotes unsickling in vitro by relieving RBC hypoxia. An in vivo rat model of vaso-occlusive crisis (VOC) capable of accommodating a suite of physiological and microcirculatory measurements was used to compare treatment with PEG-COHb to a non-oxygen carrying control solution (lactated ringer’s [LRS]). Male Sprague-Dawley rats were anesthetized and surgically prepared to monitor microvascular interstitial oxygenation (PISFO2), cardiovascular parameters and blood chemistry. Human homozygous SCD RBCs were isolated and exchange transfused into the rats until the distal microcirculation of the exteriorized spinotrapezius muscle was hypoxic and RBC aggregates were visualized. VOC was left untreated (Sham) or treated 15 min later with PEG-COHb or LRS and observed for up to 4 h. Treatment with PEG-COHb showed better improvement of PISFO2, end-point lactate, mean arterial pressure and survival duration compared to Sham and LRS. Restoring PISFO2 was associated with relieving the RBC aggregates driving VOC, which then affected other study metrics. Compared to LRS, PEG-COHb’s oxygen-carrying properties were key to improved outcomes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemoglobinopathies and Related Disorders · Hemoglobin structure and function · Heme Oxygenase-1 and Carbon Monoxide
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Song Biotechnologies
Prolong Pharmaceuticals
Funding
Prolong Pharmaceuticals LLC
References (40)
Show source-provided references
1. 10.1016/j.jsb.2017.04.00910.1016/j.jsb.2017.04.009 ↗
2. 10.1146/annurev.bb.14.060185.00132310.1146/annurev.bb.14.060185.001323 ↗
3. 10.1182/blood.V46.2.253.25310.1182/blood.V46.2.253.253 ↗
4. 10.1016/0026-2862(83)90068-710.1016/0026-2862(83)90068-7 ↗
5. Haynes J, Jr., Taylor AE, Dixon D, et al. Microvascular hemodynamics in the sickle red blood cell perfused isolated rat lung. Am J Physiol. 1993;264:H484–H489.
6. Olabode JO, Shokunbi WA. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan. West Afr J Med. 2006;25:284–288.
7. 10.1080/mic.11.2.101.11310.1080/mic.11.2.101.113 ↗
8. 10.1146/annurev-bioeng-070909-10533910.1146/annurev-bioeng-070909-105339 ↗
9. 10.1182/blood-2006-03-00140410.1182/blood-2006-03-001404 ↗
10. 10.1182/blood.V70.5.1245.124510.1182/blood.V70.5.1245.1245 ↗
11. 10.1056/NEJM19990401340130710.1056/NEJM199904013401307 ↗
12. 10.1080/mic.11.2.167.17710.1080/mic.11.2.167.177 ↗
13. 10.1016/S0002-9343(96)00407-X10.1016/S0002-9343(96)00407-X ↗
14. 10.1182/blood.V84.2.643.64310.1182/blood.V84.2.643.643 ↗
15. Yale SH, Nagib N, Guthrie T. Approach to the vaso-occlusive crisis in adults with sickle cell disease. Am Fam Physician. 2000;61:1349–1356.
16. 10.1080/0144361080266711210.1080/01443610802667112 ↗
17. 10.1111/j.1365-2141.2011.08777.x10.1111/j.1365-2141.2011.08777.x ↗
18. 10.1046/j.1365-2141.2001.02557.x10.1046/j.1365-2141.2001.02557.x ↗
19. Stirnemann J, Letellier E, Aras N, et al. Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. Diving Hyperb Med. 2012;42:82–84.
20. 10.3109/03630269.2011.59698410.3109/03630269.2011.596984 ↗
21. Odesina V. Intravenous support for the patient in sickle cell crisis. J Intraven Nurs. 2001;24:32–37.
22. 10.1111/j.1600-0609.1998.tb00989.x10.1111/j.1600-0609.1998.tb00989.x ↗
23. 10.3109/0888001920901660310.3109/08880019209016603 ↗
24. 10.1097/00043426-199208000-0000710.1097/00043426-199208000-00007 ↗
25. 10.3109/21691401.2012.76237010.3109/21691401.2012.762370 ↗
26. 10.3109/10731199.2010.48863510.3109/10731199.2010.488635 ↗
27. 10.1007/978-1-4939-3023-4_5810.1007/978-1-4939-3023-4_58 ↗
28. 10.1111/aor.1293410.1111/aor.12934 ↗
29. Nugent WH, Cestero RF, Ward K, et al. Effects of sanguinate(R) on systemic and microcirculatory variables in a model of prolonged hemorrhagic shock. Shock. 2017 [Epub ahead of print].
30. 10.1016/0026-2862(73)90055-110.1016/0026-2862(73)90055-1 ↗
31. 10.1016/S0026-2862(03)00061-X10.1016/S0026-2862(03)00061-X ↗
32. 10.1016/j.mvr.2015.12.00710.1016/j.mvr.2015.12.007 ↗
33. 10.1126/science.342041710.1126/science.3420417 ↗
34. 10.1016/S0021-9258(18)45596-210.1016/S0021-9258(18)45596-2 ↗
35. 10.7205/MILMED-D-12-0040810.7205/MILMED-D-12-00408 ↗
36. 10.1016/j.mvr.2014.07.00510.1016/j.mvr.2014.07.005 ↗
37. 10.1152/japplphysiol.01007.201510.1152/japplphysiol.01007.2015 ↗
38. 10.1080/1073968080227939410.1080/10739680802279394 ↗
39. 10.1111/vec.1221310.1111/vec.12213 ↗
40. 10.3109/1073119920911967710.3109/10731199209119677 ↗